In April\u00a0of 2014, Real Scientific Hemp Oil\u2122 (RSHO\u2122) became the first medical cannabis product to be approved for import and use in Brazil when the country allowed access for a little girl with epilepsy.<\/p>\n
With the approval of RSHO\u2122, Brazil also became the first Latin American country to approve prescriptions for any a medical cannabis product, with Mexico and Paraguay following suit less than a year later.<\/p>\n
RSHO\u2122, a medical cannabis product derived from low-THC hemp, has a high concentration of cannabidiol (CBD), a non-psychoactive compound in cannabis demonstrated to have significant antioxidant and neuroprotective effects. Although RSHO\u2122 is sold as a supplement in the U.S., it is considered a prescription medication in several Latin American countries.<\/p>\n
HempMeds\u00ae Brasil has been instrumental in creating access to medical cannabis in Brazil, a country of over 200 million people and the world\u2019s ninth largest economy. HempMeds\u00ae Brasil assists local patients in purchasing and obtaining permission from the government to import RSHO\u2122, even helping patients secure reimbursement from the government for their medication.<\/p>\n
\n
\n
HEMPMEDS\u00ae BRASIL WAS THERE FROM THE START TO HELP ORGANIZE PATIENTS AND IN ACTING TO ASSIST IN THEIR NAVIGATION OF THE APPROVAL PROCESS TO START IMPORTING RSHO\u2122<\/strong><\/h3>\n<\/strong><\/p>\n<\/strong><\/p>\nThe story of CBD being legalized in Brazil starts in Texas and stretches 5,000 miles across the globe. Searching for an alternative treatment for her daughter Anny\u2019s severe childhood epilepsy in Brazil, Katiele Fischer discovered Medical Marijuana, Inc. partner Penny Harper in Texas and learned she gave her own epileptic daughter, Harper, RSHO\u2122. Katiele took her family\u2019s case to ANVISA, the health authority in Brazil, and within three days, the Brazilian courts ruled it inhumane to keep RSHO\u2122 from Anny and granted her the first import authorization for CBD hemp oil. With the help of HempMeds\u00ae Brasil, families in Brazil organized, demanding RSHO\u2122 for their own children.<\/p>\n<\/div>\n<\/div>\n
<\/span><\/div>\n\n\nHempMeds\u00ae Brasil now works with thousands of families in need to help them legally get access to RSHO\u2122. The company is also working hard to educate the medical community and regulatory agencies to make the process for obtaining cannabis products like RSHO\u2122 easier.<\/p>\n
<\/p>\n
HempMeds\u00ae Brasil was there from the start to help organize patients and in acting to assist in their navigation of the approval process to start importing RSHO\u2122<\/strong><\/h3>\n<\/strong><\/p>\nAfter ANVISA removed CBD entirely from Brazil\u2019s prohibited substance use list, they also suspended the import tax on it. More recently, the government updated their policy to fully \u00a0subsidize any purchase of RSHO\u2122 under their healthcare system, further increasing the ability of Brazilian patients to receive RSHO\u2122.<\/p>\n<\/div>\n<\/div>\n
\n\nAlthough RSHO\u2122 was originally imported into the country as a prescription medication for epilepsy, additional indications, like Alzheimer\u2019s disease, Parkinson\u2019s disease, chronic pain, and migraines, have been approved, with a number more under consideration.<\/p>\n
<\/strong><\/p>\n The story of CBD being legalized in Brazil starts in Texas and stretches 5,000 miles across the globe. Searching for an alternative treatment for her daughter Anny\u2019s severe childhood epilepsy in Brazil, Katiele Fischer discovered Medical Marijuana, Inc. partner Penny Harper in Texas and learned she gave her own epileptic daughter, Harper, RSHO\u2122. Katiele took her family\u2019s case to ANVISA, the health authority in Brazil, and within three days, the Brazilian courts ruled it inhumane to keep RSHO\u2122 from Anny and granted her the first import authorization for CBD hemp oil. With the help of HempMeds\u00ae Brasil, families in Brazil organized, demanding RSHO\u2122 for their own children.<\/p>\n<\/div>\n<\/div>\n HempMeds\u00ae Brasil now works with thousands of families in need to help them legally get access to RSHO\u2122. The company is also working hard to educate the medical community and regulatory agencies to make the process for obtaining cannabis products like RSHO\u2122 easier.<\/p>\n <\/p>\n <\/strong><\/p>\n After ANVISA removed CBD entirely from Brazil\u2019s prohibited substance use list, they also suspended the import tax on it. More recently, the government updated their policy to fully \u00a0subsidize any purchase of RSHO\u2122 under their healthcare system, further increasing the ability of Brazilian patients to receive RSHO\u2122.<\/p>\n<\/div>\n<\/div>\n Although RSHO\u2122 was originally imported into the country as a prescription medication for epilepsy, additional indications, like Alzheimer\u2019s disease, Parkinson\u2019s disease, chronic pain, and migraines, have been approved, with a number more under consideration.<\/p>\nHempMeds\u00ae Brasil was there from the start to help organize patients and in acting to assist in their navigation of the approval process to start importing RSHO\u2122<\/strong><\/h3>\n